Skip to main content
Premium Trial:

Request an Annual Quote

Serologicals, LINCO, NIST

Premium

Serologicals to Acquire LINCO for $75M to Expand Multiplexing Products Portfolio

Serologicals announced this week that it has made an agreement to acquire LINCO, a life sciences company that focuses on supplying research assays and test kits for the Luminex-based multiplexing platform and other immunoassays.

Under terms of the agreement, Serologicals will pay $64.5 million in cash for the LINCO business, which has 109 employees, plus an additional $10.3 million for the land and buildings currently occupied by LINCO in St. Louis, Mo.

Serologicals said it expects the acquisition to be completed next month.


NIST Extends Call for RNA Sequences

The National Institute of Standards and Technology has extended to April 28 the deadline for RNA sequence contributions to be included in its first round of testing.

The sequences, which will be used in a manner mimicking portions of typical mammalian mRNA transcripts, must be released to the public domain.

NIST is building a library of RNA reference materials as part of a program with the External RNA Controls Consortium. The library of controls is expected to lead to commercial products.

Further details on selection of sequences can be found at http://www.clsi.org.

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.